Cargando…

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

Excessive myocardial collagen deposition and cross-linking (CCL), a process regulated by lysyl oxidase (LOX), determines left ventricular (LV) stiffness and dysfunction. The angiotensin II antagonist losartan, metabolized to the EXP3179 and EXP3174 metabolites, reduces myocardial fibrosis and LV sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miguel-Carrasco, José Luis, Beaumont, Javier, San José, Gorka, Moreno, María U., López, Begoña, González, Arantxa, Zalba, Guillermo, Díez, Javier, Fortuño, Ana, Ravassa, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291109/ https://www.ncbi.nlm.nih.gov/pubmed/28157237 http://dx.doi.org/10.1038/srep41865

Ejemplares similares

Blockade of TGF-β 1 Signalling Inhibits Cardiac NADPH Oxidase Overactivity in Hypertensive Rats
por: Miguel-Carrasco, José Luis, et al.
Publicado: (2012)

MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure
por: Beaumont, Javier, et al.
Publicado: (2017)

Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure
por: Beaumont, Javier, et al.
Publicado: (2020)

The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
por: Ravassa, Susana, et al.
Publicado: (2013)

Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease
por: Kovács, Mónika Gabriella, et al.
Publicado: (2021)

Does Chronic Kidney Disease Facilitate Malignant Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction of Hypertensive Origin?
por: Eiros, Rocio, et al.
Publicado: (2020)

Aging and atrial fibrillation: a matter of fibrosis
por: Ravassa, Susana, et al.
Publicado: (2019)

Differences in the Evolution of Lung Function Before and After Treatment With Antifibrotics in Patients With Interstitial Lung Disease
por: Liendo-Martínez, Katiuska Herminia, et al.
Publicado: (2023)

Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload
por: Smyrnias, Ioannis, et al.
Publicado: (2019)

Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population
por: Cauwenberghs, Nicholas, et al.
Publicado: (2019)

Antifibrotic therapies to control cardiac fibrosis
por: Fan, Zhaobo, et al.
Publicado: (2016)

NADPH Oxidase Overactivity Underlies Telomere Shortening in Human Atherosclerosis
por: Pejenaute, Álvaro, et al.
Publicado: (2020)

Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients
por: Treibel, Thomas A, et al.
Publicado: (2018)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Oxidative Stress in Cardiovascular Disease and Comorbidities
por: Zalba, Guillermo, et al.
Publicado: (2022)

Commentary: Antifibrotic medications and wound healing after cardiac surgery
por: Balsam, Leora B.
Publicado: (2020)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
por: Schimmel, Katharina, et al.
Publicado: (2020)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Medular ischemia after cardiac arrest()
por: Lozano Gómez, Herminia, et al.
Publicado: (2021)

Endothelial NOX5 overexpression induces changes in the cardiac gene profile: potential impact in myocardial infarction?
por: Cortés, Adriana, et al.
Publicado: (2023)

A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
por: de la Fuente, Ana, et al.
Publicado: (2022)

A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population
por: Zhang, Zhen-Yu, et al.
Publicado: (2017)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

Losartan improves clinical outcome in Camurati Engelmann Disease
por: Ayyavoo, Ahila, et al.
Publicado: (2013)

MicroRNA‐130a, a Potential Antifibrotic Target in Cardiac Fibrosis
por: Li, Li, et al.
Publicado: (2017)

Influence of the usual motivation for dental attendance on dental status and oral health-related quality of life
por: Montero, Javier, et al.
Publicado: (2014)

Two Variants in the Fibulin2 Gene Are Associated with Lower Systolic Blood Pressure and Decreased Risk of Hypertension
por: Vallvé, Joan-Carles, et al.
Publicado: (2012)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
por: Dong, Baiping, et al.
Publicado: (2018)

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

Antifibrotic function of cGKI in the kidney
por: Schlossmann, Jens, et al.
Publicado: (2015)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Antifibrotic therapy to normalize the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2020)

Antifibrotic Therapies: Will We Ever Get There?
por: Thompson, Alexander James, et al.
Publicado: (2010)

PPARG as therapeutic target for antifibrotic therapy
por: Ghallab, Ahmed, et al.
Publicado: (2020)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5jjsbeqam5dfio5jo1c8cioelo